ASX announcements

Date	Title
11/12/2017	Regeneus appoints Japan-based non-executive director
02/11/2017	Results of Annual General Meeting
02/11/2017	2017 Annual General Meeting - Chairman's Address to Shareholders
02/11/2017	CEO Presentation to 2017 Annual General Meeting - Highlights and Business Update for FY17
01/11/2017	Presentation on Japan First Strategy at Ord Minnett
28/09/2017	Notice of Annual General Meeting / Proxy Form
26/09/2017	Sygenus shows longer lasting effect on pain than morphine
29/08/2017	R&D Tax Incentive
22/08/2017	RGS - ASX Full Year 2017 Announcement
22/08/2017	FY17 Presentation
22/08/2017	Appendix 4G and Corporate Governance Statement
10/07/2017	United States Patent Office allows patent for Sygenus for acne
05/07/2017	Regeneus Q2 2017 Update
21/06/2017	RGS to receive milestone payment for successful Phase I
01/06/2017	Dr Duncan Thomson attends the ChinaBio Partnering Forum
24/05/2017	Japanese Patent Office to grant key patent for Progenza
22/05/2017	Positive clinical trial results for Progenza
18/04/2017	Regeneus joins Austrade's business mission in Japan
29/03/2017	Chinese patent granted on stem cell secretions technology for acne
22/02/2017	Japan Update & Half-Year Results Presentation for FY17
22/02/2017	Regeneus 2017 Half-Year Results
23/01/2017	Regeneus receives upfront payment of US$5.5m from AGC